Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b, Multicenter, Randomized, Placebocontrolled, Double-blind Study to Assess the Safety and Efficacy of AD04 in Patients With Early Alzheimer's Disease - ADVANCE

NCT07107074 is registered in ClinicalTrials.gov with ADvantage Therapeutics as lead sponsor.

NCT NCT07107074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07107074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b, Multicenter, Randomized, Placebocontrolled, Double-blind Study to Assess the Safety and Efficacy of AD04 in Patients With Early Alzheimer's Disease - ADVANCE
Lead sponsor
ADvantage Therapeutics
Phase
Phase 2
Overall status
Active, not recruiting
Start date
November 8, 2023
Completion date
July 31, 2027
Enrollment
122 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, early onset